Novel treatment for eye disease
作者： James Chen
DOI:
关键词:
摘要: This invention discloses methods, kits, and instructions to treat neovasculature diseases of the eye through administration a targeted photosensitizing agent subsequent exposure light specific wavelength sufficient photoactivate agent. The is bound composition that mediates site delivery target tissue therapeutically effective amount activated by relatively low fluence rate over prolonged period time. Diseases treatable under this invention, include: diabetic retinopathy; macular degeneration; malignant uveal melanomas.
lens.org 参考文章(92)
Nancy L. Oleinick, Malcolm E. Kenney, Boris D. Rihter, Ying-Syi Li, Phthalocyanine photosensitizers for photodynamic therapy and methods for their use ,(1993)
James Chen, Use of photoluminescent nanoparticles for photodynamic therapy ,(2002)
Dennis A. Carson, Use of photodynamic compositions for cytotoxic effects ,(1988)
James C. Chen, Transcutaneous electromagnetic energy transfer ,(1996)
Fuu-Yau Shiau, Kevin M. Smith, Thomas J. Dougherty, Ravindra K. Pandey, Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages ,(1994)
Linda M. Gustavson, John M. Reno, Sudhakar Kasina, Louis J. Theodore, Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota ,(1996)
Mark S. Blumenkranz, Stuart W. Young, Kathryn W. Woodburn, Richard A. Miller, Use of Texaphyrin in ocular diagnosis and therapy ,(1997)
Barbara A. Sosnowski, Graham A. Fleurbaaij, Erwin Freund, Kimberly D. Victor, L. L. Houston, Michael P. Nova, Conjugates of vascular endothelial growth factor with targeted agents ,(1995)